Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Moderna Inc shares valued at $1,624,836 were sold by AFEYAN NOUBAR on Apr 24 ’24. At $108.32 per share, AFEYAN NOUBAR sold 15,000 shares. The insider’s holdings dropped to 2,041,931 shares worth approximately $256.45 million following the completion of this transaction.
Also, AFEYAN NOUBAR sold 15,000 shares, netting a total of over 1,550,703 in proceeds. Following the sale of shares at $103.38 each, the insider now holds 2,056,931 shares.
Before that, Hoge Stephen had sold 15,000 shares from its account. In a trade valued at $1,575,300, the President traded Moderna Inc shares for $105.02 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $186.66 million.
As published in a research note from HSBC Securities on February 26, 2024, Moderna Inc [MRNA] has been rated down from a Hold to a Reduce and the price target has been revised to $86 from $75. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in early January. As of November 29, 2023, Canaccord Genuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Reduce”.
Analyzing MRNA Stock Performance
During the last five days, there has been a surge of approximately 18.28%. Over the course of the year, Moderna Inc shares have jumped approximately 26.28%. Shares of the company reached a 52-week high of $128.81 on 05/02/24 and a 52-week low of $84.06 on 02/13/24. A 50-day SMA is recorded $104.33, while a 200-day SMA reached $98.44. Nevertheless, trading volume fell to 11.91 million shares from 3.84 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 116.83, which, if violated, would cause prices to drop to 108.07. In the upper region, resistance lies at 131.58. The next price resistance is at 137.57. RSI (Relative Strength Index) is 73.91 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 8.01, which suggests the price will increase in the coming days. Percent R is at 10.91%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
